NO20065469L - Behandling av infeksjonssykdommer. - Google Patents

Behandling av infeksjonssykdommer.

Info

Publication number
NO20065469L
NO20065469L NO20065469A NO20065469A NO20065469L NO 20065469 L NO20065469 L NO 20065469L NO 20065469 A NO20065469 A NO 20065469A NO 20065469 A NO20065469 A NO 20065469A NO 20065469 L NO20065469 L NO 20065469L
Authority
NO
Norway
Prior art keywords
treatment
infectious diseases
derivatives
chemosensitizing
compounds
Prior art date
Application number
NO20065469A
Other languages
English (en)
Norwegian (no)
Inventor
Birgit Kjaeldgaard Giwercman
Original Assignee
Bkg Pharma Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bkg Pharma Aps filed Critical Bkg Pharma Aps
Publication of NO20065469L publication Critical patent/NO20065469L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
NO20065469A 2004-04-30 2006-11-28 Behandling av infeksjonssykdommer. NO20065469L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200400680 2004-04-30
DKPA200401716 2004-11-08
PCT/DK2005/000294 WO2005105145A1 (fr) 2004-04-30 2005-04-29 Traitement de maladies infectieuses

Publications (1)

Publication Number Publication Date
NO20065469L true NO20065469L (no) 2007-01-24

Family

ID=34965444

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065469A NO20065469L (no) 2004-04-30 2006-11-28 Behandling av infeksjonssykdommer.

Country Status (13)

Country Link
US (1) US20080318970A1 (fr)
EP (2) EP2260870A3 (fr)
JP (2) JP5026255B2 (fr)
CN (1) CN1976723B (fr)
AU (1) AU2005237208B2 (fr)
CA (1) CA2564684C (fr)
DK (1) DK1744781T3 (fr)
EA (1) EA016803B1 (fr)
ES (1) ES2390226T3 (fr)
HK (1) HK1104460A1 (fr)
MX (1) MXPA06012566A (fr)
NO (1) NO20065469L (fr)
WO (1) WO2005105145A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008080398A1 (fr) * 2007-01-05 2008-07-10 Bkg Pharma Aps Agents anti-infectieux tels que des dérivés de phénothiazine et de thioxanthène pour traiter les maladies infectieuses
EP2246349A1 (fr) * 2009-04-20 2010-11-03 BKG Pharma ApS Traitement de maladies infectieuses
EP2739285B9 (fr) * 2011-08-02 2019-09-04 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Inhibition sélective de la protéase malt1 par des dérivés de phénothiazine
EP2758403B1 (fr) 2011-09-21 2016-04-27 Inception Orion, Inc. Composés tricycliques utiles comme agents neurogènes et neuroprotecteurs
EP2760820A4 (fr) * 2011-09-29 2015-04-29 Univ Emory Analogues de sphingosine, compositions et procédés afférents
RU2663289C2 (ru) * 2012-11-26 2018-08-03 Юниверсити Оф Кейптаун Производные фенотиазина и их применение против туберкулеза
KR101798176B1 (ko) * 2014-12-16 2017-11-15 주식회사 엠디헬스케어 세균 유래의 나노소포체를 이용한 세균성 감염질환 원인균 동정방법
JP6168673B2 (ja) * 2015-10-07 2017-07-26 協和発酵キリン株式会社 アリールアルキルアミン化合物含有医薬組成物
MX2018016339A (es) 2016-06-23 2019-09-04 Bioimics Ab Compuestos heterociclicos antiinfecciosos y sus usos.
WO2018070874A1 (fr) * 2016-10-12 2018-04-19 Rijksuniversiteit Groningen Moyens et procédés pour réduire ou éviter la résistance aux antibiotiques et la propagation de virulence chez des pathogènes humains
EP3958975A1 (fr) * 2019-04-24 2022-03-02 Københavns Universitet Nouvelle classe d'antibiotiques ayant de faibles concentrations minimales inhibitrices (cmi) à l'égard de différentes souches de bactéries
CN112353805A (zh) * 2020-11-17 2021-02-12 北京化工大学 氟哌噻吨在治疗和预防柯萨奇病毒感染中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE578983A (fr) 1958-05-29
DE1518325B1 (de) 1960-03-07 1970-08-27 Smith Kline French Lab Basisch substituierte Trifluormethylxanthene und deren nicht toxische Saeureadditionssalze und Verfahren zu deren Herstellung
HU190078B (en) * 1983-03-25 1986-08-28 Egyt Gyogyszervegyeszeti Gyar,Hu Process for producing new antibacterial pharmaceutical composition and/or food-premix
NZ228748A (en) * 1988-04-20 1991-07-26 Merrell Dow Pharma Treating drug-resistant protozoal infections with a tricyclic compound and an antiprotozoal agent: composition and kit therefor
US6569853B1 (en) 2000-11-06 2003-05-27 Combinatorx, Incorporated Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders
US6989396B2 (en) * 2001-04-12 2006-01-24 The Board Of Trustees Of The University Of Illinois Tropane alkaloid multidrug resistance inhibitors from Erythroxylum pervillei and use of the same
WO2002089810A1 (fr) * 2001-05-07 2002-11-14 United States Army Medical Research And Materiel Command Agents de chimiosensibilisation contre plasmodium falciparum resistant a la chloroquine et leurs procedes d'utilisation
JP4570357B2 (ja) 2001-07-06 2010-10-27 ライフサイクル ファーマ エー／エス 制御された凝集
WO2003062388A2 (fr) * 2002-01-16 2003-07-31 The Regents Of The University Of California Inhibition de fonction arn
AU2003205543A1 (en) 2003-01-14 2004-08-10 Lifecycle Pharma A/S Dry dispersions
US8623864B2 (en) * 2003-11-13 2014-01-07 Noa Sic Aps Thioridazine and derivatives thereof for reversing anti-microbial drug-resistance

Also Published As

Publication number Publication date
MXPA06012566A (es) 2007-05-09
US20080318970A1 (en) 2008-12-25
JP2007535510A (ja) 2007-12-06
JP2012082219A (ja) 2012-04-26
EA016803B1 (ru) 2012-07-30
HK1104460A1 (en) 2008-01-18
WO2005105145A1 (fr) 2005-11-10
DK1744781T3 (da) 2012-10-15
ES2390226T3 (es) 2012-11-07
EP2260870A3 (fr) 2012-12-26
JP5026255B2 (ja) 2012-09-12
AU2005237208A1 (en) 2005-11-10
EP1744781B1 (fr) 2012-07-04
CN1976723B (zh) 2010-12-29
EA200601889A1 (ru) 2007-06-29
CA2564684C (fr) 2010-10-26
EP2260870A2 (fr) 2010-12-15
CN1976723A (zh) 2007-06-06
AU2005237208B2 (en) 2009-12-03
CA2564684A1 (fr) 2005-11-10
EP1744781A1 (fr) 2007-01-24

Similar Documents

Publication Publication Date Title
NO20065469L (no) Behandling av infeksjonssykdommer.
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
BRPI0513184A (pt) derivados de 2-carbamida-4-feniltiazol, preparação dos mesmos e aplicação dos mesmos em terapia
HRP20060254A2 (en) Phosphonates, monophosphonamidates, bisphosphonamidates for the treatment of viral diseases
NO20064186L (no) Substituerte pyrazolin sammensetninger for a redusere triglycerider i blod
BRPI0507198A (pt) derivados de bisariluréia
EA200870019A1 (ru) Лактамовые соединения и способы их применения
DK1973539T3 (da) Anvendelse af benzokondenserede heterocykliske sulfamidderivater til behandling af depression
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
EA200802213A1 (ru) Способы лечения заболеваний крови
ECSP066313A (es) Derivados de la piridazina y su uso como agentes terapéuticos
NO20064547L (no) Fremgangsmater for behandling av HIV infeksjon
NO20064078L (no) Substituerte azetidinsammensetninger, deres fremstilling og anvendelse som medikamenter
NO20081942L (no) Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser
EA200801997A1 (ru) Новые соединения
DK1973540T3 (da) Anvendelse af benzokondenserede heterocycliske sulfamidderivater til behandling af smerte
BRPI0418939A (pt) derivados de nicotinamida e sua utilização como agentes terapêuticos
EA200870086A1 (ru) Применение бензоконденсированных гетероциклических сульфамидных производных для лечения маниакального синдрома и биполярного расстройства
TW200633995A (en) Andrographolide derivatives to treat viral infections
DE602005010744D1 (de) Piperazinylpyridinderivate als mittel gegen adipositas
ME00979B (me) DERIVATI INDOL-2-ONA, DISUPSTITUISANI NA 3-POZICIJI, NJIHOVO DOBIJANJE l PRIMJENA U TERAPIJI
CY1111778T1 (el) Παραγωγα θειοξανθενιου ως μοναδικοι αντιμολυσματικοι παραγοντες για χρηση στην αντιμετωπιση των μολυσματικων ασθενειων
NO20076405L (no) Anvendelse av 24-nor-UDCA
ATE508125T1 (de) Triazoloanilinopyrimidinderivate zur verwendung als antivirale mittel
EA200701813A1 (ru) Новые амидозамещенные 6-фенилфенантридины

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application